Clinical significance of prospectively assigned Gleason tertiary pattern 4 in contemporary Gleason score 3+3=6 prostate cancer

Prostate

Volumn 76, Issue 8, 2016, Pages 715-721

  Doshi, Chirag ^a   Vacchio, Michael ^a   Attwood, Kristopher ^a   Murekeyisoni, Christine ^a   Mehedint, Diana C ^a   Badkhshan, Shervin ^a   Azabdaftari, Gissou ^a   Sule, Norbert ^a   Guru, Khurshid A ^a,b   Mohler, James L ^a,b   Kauffman, Eric C ^a,b  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

biochemical failure; prostate cancer; radical prostatectomy; tertiary Gleason pattern

Indexed keywords

ADULT; ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; FOLLOW UP; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; INCIDENCE; MALE; METASTASIS FREE SURVIVAL; OUTCOME ASSESSMENT; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; RISK ASSESSMENT; AGED; CANCER GRADING; DISEASE COURSE; DISEASE FREE SURVIVAL; FACTUAL DATABASE; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROSTATE; PROSTATIC NEOPLASMS; SURVIVAL RATE;

AGED; DATABASES, FACTUAL; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84959017753     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.23166     Document Type: Article

References (31)

1. Gleason DF,. Classification of prostatic carcinomas. Cancer Chemother Rep 1966; 50 (3): 125-128.
2. Mohler JL, Kantoff PW, Armstrong AJ, Bahnson RR, Cohen M, D'Amico AV, Eastham JA, Enke CA, Farrington TA, Higano CS, Horwitz EM, Kane CJ, Kawachi MH, Kuettel M, Kuzel TM, Lee RJ, Malcolm AW, Miller D, Plimack ER, Pow-Sang JM, Raben, D, Richey, S, Roach, M, 3rd, Rohren, E, Rosenfeld, S, Schaeffer, E, Small, EJ, Sonpavde, G, Srinivas, S, Stein, C, Strope, SA, Tward, J, Shead, DA, Ho, M. Prostate cancer, version 2.2014. J Natl Compr Canc Netw 2014; 12 (5): 686-718.
3. Gleason DF,. Histologic grading of prostatic carcinoma. In:, Bostwick DG, editor. Pathology of the prostate. New York: Churchill Livingstone; 1990. pp. 83-93.
4. Pierorazio PM, Walsh PC, Partin AW, Epstein JI,. Prognostic Gleason grade grouping: Data based on the modified Gleason scoring system. BJU Int 2013; 111 (5): 753-760.
5. Murphy GP, Whitmore WF, Jr., A report of the workshops on the current status of the histologic grading of prostate cancer. Cancer 1979; 44 (4): 1490-1494.
6. Epstein JI, Zelefsky MJ, Sjoberg DD, Nelson JB, Egevad L, Magi-Galluzzi C, Vickers AJ, Parwani AV, Reuter VE, Fine SW, Eastham JA, Wiklund P, Han M, Reddy CA, Ciezki JP, Nyberg T, Klein EA,. A contemporary prostate cancer grading system: A validated alternative to the Gleason score. Eur Urol 2015; DOI: 10.1016/j.eururo.2015.06.046. [Epub ahead of print]
7. Hashine K, Yuasa A, Shinomori K, Shirato A, Ninomiya I, Teramoto N,. Tertiary Gleason pattern 5 and oncological outcomes after radical prostatectomy. Jpn J Clin Oncol 2011; 41 (4): 571-576.
8. Hattab EM, Koch MO, Eble JN, Lin H, Cheng L,. Tertiary Gleason pattern 5 is a powerful predictor of biochemical relapse in patients with Gleason score 7 prostatic adenocarcinoma. J Urol 2006; 175 (5): 1695-1699; discussion 9.
9. Isbarn H, Ahyai SA, Chun FK, Budaus L, Schlomm T, Salomon G, Zacharias M, Erbersdobler A, Kollermann J, Sauter G, Huland H, Graefen M, Steuber T,. Prevalence of a tertiary Gleason grade and its impact on adverse histopathologic parameters in a contemporary radical prostatectomy series. Eur Urol 2009; 55 (2): 394-401.
10. Mosse CA, Magi-Galluzzi C, Tsuzuki T, Epstein JI,. The prognostic significance of tertiary Gleason pattern 5 in radical prostatectomy specimens. Am J Surg Pathol 2004; 28 (3): 394-398.
11. Servoll E, Saeter T, Vlatkovic L, Lund T, Nesland J, Waaler G, Axcrona K, Beisland HO,. Impact of a tertiary Gleason pattern 4 or 5 on clinical failure and mortality after radical prostatectomy for clinically localised prostate cancer. BJU Int 2012; 109 (10): 1489-1494.
12. Sim HG, Telesca D, Culp SH, Ellis WJ, Lange PH, True LD, Lin DW,. Tertiary Gleason pattern 5 in Gleason 7 prostate cancer predicts pathological stage and biochemical recurrence. J Urology 2008; 179 (5): 1775-1779.
13. Trock BJ, Guo CC, Gonzalgo ML, Magheli A, Loeb S, Epstein JI,. Tertiary Gleason patterns and biochemical recurrence after prostatectomy: Proposal for a modified Gleason scoring system. J Urol 2009; 182 (4): 1364-1370.
14. Turker P, Bas E, Bozkurt S, Gunlusoy B, Sezgin A, Postaci H, Turkeri L,. Presence of high grade tertiary Gleason pattern upgrades the Gleason sum score and is inversely associated with biochemical recurrence-free survival. Urol Oncol 2013; 31 (1): 93-98.
15. van Oort IM, Schout BM, Kiemeney LA, Hulsbergen CA, Witjes JA,. Does the tertiary Gleason pattern influence the PSA progression-free interval after retropubic radical prostatectomy for organ-confined prostate cancer ? Eur Urol 2005; 48 (4): 572-576.
16. Pan CC, Potter SR, Partin AW, Epstein JI,. The prognostic significance of tertiary Gleason patterns of higher grade in radical prostatectomy specimens: A proposal to modify the Gleason grading system. Am J Surg Pathol 2000; 24 (4): 563-569.
17. Rasiah KK, Stricker PD, Haynes AM, Delprado W, Turner JJ, Golovsky D, Brenner PC, Kooner R, O'Neill GF, Grygiel JJ, Sutherland RL, Henshall SM,. Prognostic significance of Gleason pattern in patients with Gleason score 7 prostate carcinoma. Cancer 2003; 98 (12): 2560-2565.
18. Epstein JI, Allsbrook WC, Jr., Amin MB, Egevad LL,. The 2005 International Society of Urological Pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma. Am J Surg Pathol 2005; 29 (9): 1228-1242.
19. Adam M, Hannah A, Budaus L, Steuber T, Salomon G, Michl U, Haese A, Fisch M, Wittmer C, Steurer S, Minner S, Heinzer H, Huland H, Graefen M, Sauter G, Schlomm T, Isbarn H,. A tertiary Gleason pattern in the prostatectomy specimen and its association with adverse outcome after radical prostatectomy. J Urol 2014; 192 (1): 97-101.
20. Cooperberg MR, Cowan JE, Hilton JF, Reese AC, Zaid HB, Porten SP, Shinohara K, Meng MV, Greene KL, Carroll PR,. Outcomes of active surveillance for men with intermediate-risk prostate cancer. J Clin Oncol 2011; 29 (2): 228-234.
21. Wilt TJ, Brawer MK, Jones KM, Barry MJ, Aronson WJ, Fox S, Gingrich JR, Wei JT, Gilhooly P, Grob BM, Nsouli I, Iyer P, Cartagena R, Snider G, Roehrborn C, Sharifi R, Blank W, Pandya P, Andriole GL, Culkin D, Wheeler T,. Radical prostatectomy versus observation for localized prostate cancer. New Engl J Med 2012; 367 (3): 203-213.
22. Loeb S, Feng Z, Ross A, Trock BJ, Humphreys EB, Walsh PC,. Can we stop prostate specific antigen testing 10 years after radical prostatectomy ? J Urol 2011; 186 (2): 500-505.
23. Bolton DM, Ta A, Bagnato M, Muller D, Lawrentschuk NL, Severi G, Syme RR, Giles GG,. Interval to biochemical recurrence following radical prostatectomy does not affect survival in men with low-risk prostate cancer. World J Urol 2014; 32 (2): 431-435.
24. McGowan DG, Bain GO, Hanson J,. Evaluation of histological grading (Gleason) in carcinoma of the prostate: Adverse influence of highest grade. Prostate 1983; 4 (2): 111-118.
25. Gleason DF,. Histologic grading of prostate cancer: A perspective. Human Pathol 1992; 23 (3): 273-279.
26. Aihara M, Wheeler TM, Ohori M, Scardino PT,. Heterogeneity of prostate cancer in radical prostatectomy specimens. Urology 1994; 43 (1): 60-66; discussion 6-7.
27. Patel AA, Chen MH, Renshaw AA, D'Amico AV,. PSA failure following definitive treatment of prostate cancer having biopsy Gleason score 7 with tertiary grade 5. JAMA 2007; 298 (13): 1533-1538.
28. Whittemore DE, Hick EJ, Carter MR, Moul JW, Miranda-Sousa AJ, Sexton WJ,. Significance of tertiary Gleason pattern 5 in Gleason score 7 radical prostatectomy specimens. J Urol 2008; 179 (2): 516-522; discussion 22.
29. Servoll E, Saeter T, Vlatkovic L, Nesland J, Waaler G, Beisland HO,. Does a tertiary Gleason pattern 4 or 5 influence the risk of biochemical relapse after radical prostatectomy for clinically localized prostate cancer ? Scand J Urol Nephrol 2010; 44 (4): 217-222.
30. Ross HM, Kryvenko ON, Cowan JE, Simko JP, Wheeler TM, Epstein JI,. Do adenocarcinomas of the prostate with Gleason score (GS)
31. Kweldam CF, Wildhagen MF, Bangma CH, van Leenders GJ,. Disease-specific death and metastasis do not occur in patients with Gleason score